dabigatran etexilate - Generic mfg.
Praxbind (idarucizumab) - Boehringer Ingelheim
Safety and efficacy of idarucizumab-assisted thrombolysis in dabigatran-related acute ischemic stroke: a systematic review and single-arm meta-analysis. (PubMed, Front Neurol) - Sep 5, 2026 - "However, these findings provide useful effect-size estimates (sICH ~5%, good outcome ~67%) for designing future randomised controlled trials. Multicenter prospective registries or pragmatic RCTs are warranted." 
Clinical • Journal • Retrospective data • Review • Cardiovascular • Cerebral Hemorrhage • CNS Disorders • Hematological Disorders • Ischemic stroke
http://www.ncbi.nlm.nih.gov/pubmed/42694037
 
Hang Xiong; Lingbo Kong; Qian Liu; Wei Li; Wenping Li; Xiaoyuan Guo; Xinxing Lai
 
Sep 5, 2026
 
Prev Next